This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Betriu, C.
Right arrow Articles by Picazo, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Betriu, C.
Right arrow Articles by Picazo, J. J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2003, p. 1112-1114, Vol. 47, No. 3
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.3.1112-1114.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Erythromycin and Clindamycin Resistance and Telithromycin Susceptibility in Streptococcus agalactiae

C. Betriu,* E. Culebras, M. Gómez, I. Rodríguez-Avial, B. A. Sánchez, M. C. Ágreda, and J. J. Picazo

Department of Clinical Microbiology, Hospital Clínico San Carlos, 28040 Madrid, Spain

Received 19 September 2002/ Returned for modification 25 October 2002/ Accepted 24 November 2002

The rates of resistance to erythromycin and clindamycin among Streptococcus agalactiae strains isolated in our hospital increased from 4.2 and 0.8% in 1993 to 17.4 and 12.1%, respectively, in 2001. Erythromycin resistance was mainly due to the presence of an Erm(B) methylase, while the M phenotype was detected in 3.8% of the strains. Telithromycin was very active against erythromycin-resistant strains, irrespective of their mechanisms of macrolide resistance.


* Corresponding author. Mailing address: Department of Clinical Microbiology, Hospital Clínico San Carlos, Plaza Cristo Rey s/n, 28040 Madrid, Spain. Phone: 34 913303486. Fax: 34 913303478. E-mail: cbetriu{at}efd.net.


Antimicrobial Agents and Chemotherapy, March 2003, p. 1112-1114, Vol. 47, No. 3
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.3.1112-1114.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Domelier, A.-S., van der Mee-Marquet, N., Arnault, L., Mereghetti, L., Lanotte, P., Rosenau, A., Lartigue, M.-F., Quentin, R. (2008). Molecular characterization of erythromycin-resistant Streptococcus agalactiae strains. J Antimicrob Chemother 62: 1227-1233 [Abstract] [Full Text]  
  • Amezaga, M. R., McKenzie, H. (2006). Molecular epidemiology of macrolide resistance in {beta}-haemolytic streptococci of Lancefield groups A, B, C and G and evidence for a new mef element in group G streptococci that carries allelic variants of mef and msr(D). J Antimicrob Chemother 57: 443-449 [Abstract] [Full Text]  
  • Marimon, J. M., Valiente, A., Ercibengoa, M., Garcia-Arenzana, J. M., Perez-Trallero, E. (2005). Erythromycin Resistance and Genetic Elements Carrying Macrolide Efflux Genes in Streptococcus agalactiae. Antimicrob. Agents Chemother. 49: 5069-5074 [Abstract] [Full Text]  
  • Culebras, E., Rodriguez-Avial, I., Betriu, C., Picazo, J. J. (2005). Differences in the DNA sequence of the translational attenuator of several constitutively expressed erm(A) genes from clinical isolates of Streptococcus agalactiae. J Antimicrob Chemother 56: 836-840 [Abstract] [Full Text]  
  • Gonzalez, J. J., Andreu, A., the Spanish Group for the Study of Perinatal Infec, (2005). Multicenter Study of the Mechanisms of Resistance and Clonal Relationships of Streptococcus agalactiae Isolates Resistant to Macrolides, Lincosamides, and Ketolides in Spain. Antimicrob. Agents Chemother. 49: 2525-2527 [Abstract] [Full Text]  
  • Kasbekar, N., Acharya, P. S. (2005). Telithromycin: The first ketolide for the treatment of respiratory infections. Am J Health Syst Pharm 62: 905-916 [Abstract] [Full Text]  
  • Desjardins, M., Delgaty, K. L., Ramotar, K., Seetaram, C., Toye, B. (2004). Prevalence and Mechanisms of Erythromycin Resistance in Group A and Group B Streptococcus: Implications for Reporting Susceptibility Results. J. Clin. Microbiol. 42: 5620-5623 [Abstract] [Full Text]  
  • Malbruny, B., Werno, A. M., Anderson, T. P., Murdoch, D. R., Leclercq, R. (2004). A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand. J Antimicrob Chemother 54: 1040-1044 [Abstract] [Full Text]  
  • Fluegge, K., Supper, S., Siedler, A., Berner, R. (2004). Antibiotic Susceptibility in Neonatal Invasive Isolates of Streptococcus agalactiae in a 2-Year Nationwide Surveillance Study in Germany. Antimicrob. Agents Chemother. 48: 4444-4446 [Abstract] [Full Text]  
  • Uh, Y., Jang, I. H., Hwang, G. Y., Lee, M. K., Yoon, K. J., Kim, H. Y. (2004). Antimicrobial Susceptibility Patterns and Macrolide Resistance Genes of {beta}-Hemolytic Streptococci in Korea. Antimicrob. Agents Chemother. 48: 2716-2718 [Abstract] [Full Text]  
  • Uh, Y., Jang, I. H., Hwang, G. Y., Lee, M. K., Yoon, K. J., Kim, H. Y. (2004). Serotypes and Genotypes of Erythromycin-Resistant Group B Streptococci in Korea. J. Clin. Microbiol. 42: 3306-3308 [Abstract] [Full Text]  
  • Bingen, E., Doit, C., Bidet, P., Brahimi, N., Deforche, D. (2004). Telithromycin Susceptibility and Genomic Diversity of Macrolide-Resistant Serotype III Group B Streptococci Isolated in Perinatal Infections. Antimicrob. Agents Chemother. 48: 677-680 [Abstract] [Full Text]  
  • Miller, M. B., Allen, S. L., Mangum, M. E., Doutova, A., Gilligan, P. H. (2004). Prevalence of Vancomycin-Resistant Enterococcus in Prenatal Screening Cultures. J. Clin. Microbiol. 42: 855-857 [Abstract] [Full Text]  
  • Betriu, C., Culebras, E., Rodriguez-Avial, I., Gomez, M., Sanchez, B. A., Picazo, J. J. (2004). In Vitro Activities of Tigecycline against Erythromycin-Resistant Streptococcus pyogenes and Streptococcus agalactiae: Mechanisms of Macrolide and Tetracycline Resistance. Antimicrob. Agents Chemother. 48: 323-325 [Abstract] [Full Text]